Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes
Public ClinicalTrials.gov record NCT01232491. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 26-week Randomised, Controlled, Open Label, Multicentre, Multinational, Treat to Target Trial Investigating the Impact of Dietary Intervention on Weight Change and the Relationship Between Weight Change and Baseline Body Mass Index (BMI) in Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs) Initiating Insulin Therapy With Insulin Detemir in Combination With Metformin (Levemir DIET)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted in Europe, and North and South America. The aim of this trial is to investigate if a dietary intervention has an effect on weight when initiating insulin treatment in subjects with type 2 diabetes currently treated with oral antidiabetic drugs (OADs).
Study identification
- NCT ID
- NCT01232491
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 611 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 28, 2010
- Primary completion
- Oct 31, 2011
- Completion
- Nov 13, 2011
- Last update posted
- Apr 30, 2017
2010 – 2011
United States locations
- U.S. sites
- 76
- U.S. states
- 30
- U.S. cities
- 66
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Birmingham | Alabama | 35233 | — |
| Novo Nordisk Investigational Site | Ozark | Alabama | 36360 | — |
| Novo Nordisk Investigational Site | Anaheim | California | 92801 | — |
| Novo Nordisk Investigational Site | Burlingame | California | 94010 | — |
| Novo Nordisk Investigational Site | Concord | California | 94520 | — |
| Novo Nordisk Investigational Site | Fullerton | California | 92835 | — |
| Novo Nordisk Investigational Site | Long Beach | California | 90806 | — |
| Novo Nordisk Investigational Site | Long Beach | California | 90807 | — |
| Novo Nordisk Investigational Site | Long Beach | California | 90822 | — |
| Novo Nordisk Investigational Site | Montclair | California | 91763 | — |
| Novo Nordisk Investigational Site | National City | California | 91950 | — |
| Novo Nordisk Investigational Site | Redlands | California | 92374 | — |
| Novo Nordisk Investigational Site | Santa Ana | California | 92705 | — |
| Novo Nordisk Investigational Site | Spring Valley | California | 91978 | — |
| Novo Nordisk Investigational Site | Walnut Creek | California | 94598 | — |
| Novo Nordisk Investigational Site | Colorado Springs | Colorado | 80907 | — |
| Novo Nordisk Investigational Site | Norwalk | Connecticut | 06851 | — |
| Novo Nordisk Investigational Site | Bradenton | Florida | 34201 | — |
| Novo Nordisk Investigational Site | Clearwater | Florida | 33765 | — |
| Novo Nordisk Investigational Site | Jacksonville | Florida | 32204 | — |
| Novo Nordisk Investigational Site | Jacksonville | Florida | 32207 | — |
| Novo Nordisk Investigational Site | Jupiter | Florida | 33458 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33135 | — |
| Novo Nordisk Investigational Site | Pembroke Pines | Florida | 33027 | — |
| Novo Nordisk Investigational Site | Pembroke Pines | Florida | 33028 | — |
| Novo Nordisk Investigational Site | Pembroke Pines | Florida | 33029 | — |
| Novo Nordisk Investigational Site | Atlanta | Georgia | 30342 | — |
| Novo Nordisk Investigational Site | Perry | Georgia | 31069 | — |
| Novo Nordisk Investigational Site | Roswell | Georgia | 30076 | — |
| Novo Nordisk Investigational Site | Oympiafields | Illinois | 60641 | — |
| Novo Nordisk Investigational Site | Evansville | Indiana | 47714 | — |
| Novo Nordisk Investigational Site | Shawnee Mission | Kansas | 66204 | — |
| Novo Nordisk Investigational Site | Topeka | Kansas | 66606 | — |
| Novo Nordisk Investigational Site | Louisville | Kentucky | 40213 | — |
| Novo Nordisk Investigational Site | Portland | Maine | 04101 | — |
| Novo Nordisk Investigational Site | Rockville | Maryland | 20852 | — |
| Novo Nordisk Investigational Site | Brockton | Massachusetts | 02301 | — |
| Novo Nordisk Investigational Site | Buckley | Michigan | 49620 | — |
| Novo Nordisk Investigational Site | Southfield | Michigan | 48034 | — |
| Novo Nordisk Investigational Site | St Louis | Missouri | 63141 | — |
| Novo Nordisk Investigational Site | Berlin | New Jersey | 08009 | — |
| Novo Nordisk Investigational Site | New York | New York | 10025 | — |
| Novo Nordisk Investigational Site | Northport | New York | 11768 | — |
| Novo Nordisk Investigational Site | West Seneca | New York | 14224 | — |
| Novo Nordisk Investigational Site | Charlotte | North Carolina | 28277 | — |
| Novo Nordisk Investigational Site | Durham | North Carolina | 27710 | — |
| Novo Nordisk Investigational Site | Raleigh | North Carolina | 27609 | — |
| Novo Nordisk Investigational Site | Wilmington | North Carolina | 28401 | — |
| Novo Nordisk Investigational Site | Cincinnati | Ohio | 45245 | — |
| Novo Nordisk Investigational Site | Dayton | Ohio | 45406 | — |
| Novo Nordisk Investigational Site | Dayton | Ohio | 45439 | — |
| Novo Nordisk Investigational Site | Oklahoma City | Oklahoma | 73103 | — |
| Novo Nordisk Investigational Site | Oklahoma City | Oklahoma | 73104-5020 | — |
| Novo Nordisk Investigational Site | Altoona | Pennsylvania | 16602 | — |
| Novo Nordisk Investigational Site | Jenkintown | Pennsylvania | 19046 | — |
| Novo Nordisk Investigational Site | Norristown | Pennsylvania | 19401 | — |
| Novo Nordisk Investigational Site | Anderson | South Carolina | 29621 | — |
| Novo Nordisk Investigational Site | Greer | South Carolina | 29651 | — |
| Novo Nordisk Investigational Site | Rapid City | South Dakota | 57701 | — |
| Novo Nordisk Investigational Site | Bristol | Tennessee | 37620-7352 | — |
| Novo Nordisk Investigational Site | Chattanooga | Tennessee | 37411 | — |
| Novo Nordisk Investigational Site | Kingsport | Tennessee | 37660 | — |
| Novo Nordisk Investigational Site | Nashville | Tennessee | 37212 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75231 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75246 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75251 | — |
| Novo Nordisk Investigational Site | Odessa | Texas | 79761 | — |
| Novo Nordisk Investigational Site | Plano | Texas | 75075 | — |
| Novo Nordisk Investigational Site | St. George | Utah | 84790 | — |
| Novo Nordisk Investigational Site | Norfolk | Virginia | 23502 | — |
| Novo Nordisk Investigational Site | Richmond | Virginia | 23249 | — |
| Novo Nordisk Investigational Site | Richmond | Virginia | 23294 | — |
| Novo Nordisk Investigational Site | Winchester | Virginia | 22601 | — |
| Novo Nordisk Investigational Site | Spokane | Washington | 99208 | — |
| Novo Nordisk Investigational Site | Martinsburg | West Virginia | 25401 | — |
| Novo Nordisk Investigational Site | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.
Recently updated Diabetes trials
Other public records listing Diabetes. Sorted by last update posted; newest first. Not a recommendation.
- NCT07784127: Whole Gut Motility Abnormalities Following GLP-1 Receptor Agonist (GLP-1RA) Initiation Not yet recruiting
- NCT07748858: Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities Recruiting
- NCT05561595: Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma Recruiting
- NCT05912647: Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes Recruiting
- NCT07676188: Leveraging Interventions for Needs and Knowledge in Diabetes (LINKD) Not yet recruiting
- NCT07674420: Wearable Insoles for Recurrent Diabetic Ulcer Prevention Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01232491, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 30, 2017 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01232491 live on ClinicalTrials.gov.